Interní Med. 2019; 21(1): 20-23 | DOI: 10.36290/int.2019.003

Diabetes mellitus after organ transplantation

MUDr. Dominika Goldmannová, MUDr. Ondřej Krystyník, doc. MUDr. David Karásek, Ph.D.,, prof. MUDr. Josef Zadražil, CSc.
III. interní klinika – nefrologická, revmatologická a endokrinologická, Fakultní nemocnice Olomouc

Diabetes mellitus is a very common metabolic disease with a rising incidence. I tis both leading cause of chronic renal disease and one of the most seriois complication in solid organ recipients. Post-transplant diabetes mellitus (PTDM) is associated with higher rate of cardiovascular complications and poor graft function affecting patients morbidity and mortality. Risk factors can be divided into non-modifiable (age, gender, race, genetic backround) and modifiable (obesity, proteinuria, perioperative proteinuria, infection, immunossuppressive drugs). Pre- and post-transplant management can be designed by the risk factors and therefore we could reduce the incidence and impact of PTDM.

Keywords: diabetes mellitus, organ transplantation

Published: February 21, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Goldmannová Ondřej Krystyník David Karásek D, Zadražil J. Diabetes mellitus after organ transplantation. Interní Med. 2019;21(1):20-23. doi: 10.36290/int.2019.003.
Download citation

References

  1. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3(2):178-185. Go to original source... Go to PubMed...
  2. Chadban S. New-onset diabetes after transplantation should it be a factor in choosing an immunosuppressant regimen for kidney transplant recipients. Nephrol Dial Transplant 2008; 23(6): 1816-1818. Go to original source... Go to PubMed...
  3. Davidson J, Wilkinson A, Dantal J, Dotta F, Haller H, Hernández D, Kasiske BL, Kiberd B, Krentz A, Legendre C, Marchetti P, Markell M, Van der Woude FJ, Wheeler DC; International Expert Panel. New-onset diabetes after transplantation: 2003 International Consensus Guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation 2003; 75(10 Suppl): SS3-SS24. Go to original source... Go to PubMed...
  4. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003; 26(Suppl. 1): S5-S20. Go to original source... Go to PubMed...
  5. Cosio FG, Pesavento TE, Osei K, Henry ML, Ferguson RM. Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 2001; 59(2): 732-7327. Go to original source... Go to PubMed...
  6. Sumrani NB, Delaney V, Ding ZK, Davis R, Daskalakis P, Friedman EA, Butt KM, Hong JH. Diabetes mellitus after renal transplantation in the cyclosporine era-an analysis of risk factors. Transplantation 1991; 51(2): 343-347. Go to original source... Go to PubMed...
  7. Hamer RA, Chow CL, Ong AC, McKane WS. Polycystic kidney disease is a risk factor for new-onset diabetes after transplantation. Transplantation 2007; 83(1): 36-40. Go to original source... Go to PubMed...
  8. Bayés, B., Granada, M.L., Pastor, M.C., Lauzurica, R., Salinas, I., Sanmartí, A., Espinal, A., Serra, A., Navarro, M., Bonal, J., Romero, R., 2007. Obesity, adiponectin and inflammation as predictors of new-onset diabetes mellitus after kidney transplantation. Am. J. Transplant. 7, 416-422. doi: 10.1111/j.1600-6143.2006.01646 Go to original source... Go to PubMed...
  9. Roland M, Gatault P, Al-Najjar A, Doute C, Barbet C, Chatelet V, Laouad I, Marli?re JF, Nivet H, Büchler M, Lebranchu Y, Halimi JM. Early pulse pressure and low-grade proteinuria as independent long-term risk factors for new-onset diabetes mellitus after kidney transplantation. Am J Transplant 2008; 8(8): 1719-1728. Go to original source... Go to PubMed...
  10. Fabrizi F, Martin P, Dixit V, Bunnapradist S, Kanwal F, Dulai G. Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: meta-analysis of clinical studies. Am J Transplant 2005; 5(10): 2433-2440. Go to original source... Go to PubMed...
  11. Behzad E, Mohsen M, Mahmood S, Mehrdad E, Mehrdad T. The impact of cytomegalovirus infection on new onset diabetes mellitus after kidney transplantation: a review on current findings. J Nephropathol 2014; 3(4): 139-148. Go to PubMed...
  12. Luan FL, Steffick DE, Ojo AO. New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression. Transplantation 2011; 91(3): 334-341. Go to original source... Go to PubMed...
  13. Pirsch JD, Henning AK, First MR, Fitzsimmons W, Gaber AO, Reisfield R, Shihab F, Woodle ES. New-Onset Diabetes After Transplantation: Results From a Double-Blind Early Corticosteroid Withdrawal Trial. Am J Transplant. 2015 Jul; 15(7): 1982-1990. Go to original source... Go to PubMed...
  14. Vincenti F, Friman S, Scheuermann E, Rostaing L, Jenssen T, Campistol JM, Uchida K, Pescovitz MD, Marchetti P, Tuncer M, Citterio F, Wiecek A, Chadban S, El-Shahawy M, Budde K, Goto N; DIRECT (Diabetes Incidence after Renal Transplantation: Neoral C Monitoring Versus Tacrolimus) Investigators. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 2007; 7(6): 1506-1514. Go to original source... Go to PubMed...
  15. Johnston O, Rose CL, Webster AC, Gill JS. Sirolimus is associated with new-onset diabetes in kidney transplant recipients. J Am Soc Nephrol 2008; 19(7): 1411-1418. Go to original source... Go to PubMed...
  16. Sharif A, Shabir S, Chand S, Cockwell P, Ball S, Borrows R. Meta-analysis of calcineurin-inhibitor sparing regimens in kidney transplantation. J Am Soc Nephrol 2011; 22(11): 2107-2118 Go to original source... Go to PubMed...
  17. Pham PT, Pham PM, Pham SV, Pham PA, Pham PC. New onset diabetes after transplantation (NODAT): an overview. Diabetes Metab Syndr Obes 2011; 4: 175-186. Go to original source... Go to PubMed...
  18. Potluri K, Hou S. Obesity in kidney transplant recipients and candidates. Am J Kidney Dis 2010; 56(1): 143-156. Go to original source... Go to PubMed...
  19. The Diabetes Control and Complications Trial Research Group. Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, Rand L, Siebert C. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329: 977-986. Go to original source... Go to PubMed...
  20. Goldmannova D, Spurna J, Krystynik O, Schovanek J, Cibickova L, Karasek D, Zadrazil J. Adipocytokines and new onset diabetes mellitus after transplantation. In press. doi. org/10.1016/j.jab.2018.05.005




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.